Adam Davidson, CEO of Trident Royalties, discusses offtake milestones and catalysts to boost FY24. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMMC.L Regulatory News (MMC)

  • There is currently no data for MMC

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Sale of Kurt Salmon US healthcare business

12 Jul 2016 08:20

RNS Number : 9110D
Management Consulting Group PLC
12 July 2016
 

12 July 2016

 

 

Sale of Kurt Salmon US healthcare business

Sale of the non-core healthcare consulting business will allow MCG to focus on

Kurt Salmon's market leading international retail and consumer goods practice

 

MCG today announces that it has entered into an agreement for the sale of the healthcare consulting business of Kurt Salmon in the United States to ECG Management Consultants. The cash consideration payable on completion of the sale is expected to be approximately $12.0 million (equivalent to approximately £9.2 million). A further $1 million of consideration is deferred and contingent on post completion performance.

MCG is expected to receive net cash proceeds, excluding deferred consideration, of approximately $10.4 million (equivalent to approximately £8.0 million) after the deduction of estimated transaction costs of $1.6 million (equivalent to £1.2 million). The net proceeds will be subject to tax. MCG will use the net proceeds after tax for general corporate purposes.

The Kurt Salmon healthcare business provides management consulting services to major hospital groups and healthcare organisations throughout the United States. The profit before tax attributable to the Kurt Salmon healthcare business for the year ended 31 December 2015 was £0.7 million (Group: loss before tax £3.7 million). The gross assets of the Kurt Salmon healthcare business at 31 December 2015 were £4.3m, excluding goodwill.

The Kurt Salmon business which will be retained by MCG following the disposal comprises the international consulting practice focusing on clients in the retail and consumer goods sectors, and currently principally operating in the United States, Canada, the United Kingdom, Germany, Japan and China. Kurt Salmon is an established international brand and a leading management consulting firm addressing clients in the retail and consumer goods sector. The Kurt Salmon business which will be retained by MCG represented approximately 80% of the revenues of the continuing operations of Kurt Salmon as a whole for the year ended 31 December 2015.

The business which is being sold does not generate synergies with the larger retail and consumer goods practice of Kurt Salmon and as part of the MCG group its potential for investment is limited. The disposal provides an opportunity for the Group to concentrate on the retained business of Kurt Salmon, which is wholly focused on clients in the global retail and consumer goods sector, and Alexander Proudfoot. The disposal is subject to customary closing conditions, but is expected to complete by the end of July.

The disposal is expected to generate a one-off IFRS loss before tax of approximately £15 million, principally as a result of the write off of goodwill held in the consolidated balance sheet of the Group which will be allocated to the business being sold. The Group profit and loss account will also include non-recurring expenses relating to the disposal, including in relation to the restructuring of certain non-US healthcare consulting operations which are not part of the sale. The Board believes that the disposal will not be accretive to earnings per share. The disposal will strengthen the financial position of the Group by increasing the level of cash resources available to the remaining businesses.

 

Nick Stagg, Chief Executive, commented:

"The sale of the healthcare practice, which follows the sale of the French and related operations of Kurt Salmon in January 2016, will allow MCG to focus on the Kurt Salmon business serving the retail and consumer goods sector, where it is a market leader, as well as the ongoing recovery in Alexander Proudfoot. MCG is in a strong financial position, debt free, and now well placed to promote profitable growth in its more focused continuing operations."

For further information please contact:

 

Management Consulting Group PLC

Nick Stagg

Chief Executive

020 7710 5000

Chris Povey

Finance Director

020 7710 5000

FTI Consulting

Victoria Foster Mitchell / Ben Atwell

020 3727 1000

  

ECG Management Consultants

Gary K. Edmiston

Chief Executive Officer

858 436 3220

Susan Arnold

Marketing Director

303-841-7774

 

Notes to Editors

Management Consulting Group PLC (MMC.L) provides professional services across a wide range of industries and sectors.

 

It comprises two independently managed practices: Alexander Proudfoot and Kurt Salmon, which both operate worldwide. Alexander Proudfoot helps clients to embed disciplined execution in their operations to achieve growth targets, revenue and profit goals. Kurt Salmon provides consulting services to clients in the retail and consumer goods sector. For further information, visit www.mcgplc.com.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCUUABRNWABARR
Date   Source Headline
15th Aug 20137:00 amRNSTransaction in Own Shares
12th Aug 20134:20 pmRNSHolding(s) in Company
9th Aug 20131:12 pmRNSHolding(s) in Company
8th Aug 20137:00 amRNSTransaction in Own Shares
7th Aug 20137:00 amRNSTransaction in Own Shares
6th Aug 201312:10 pmRNSHolding(s) in Company
5th Aug 201311:50 amRNSHolding(s) in Company
2nd Aug 20133:09 pmRNSHolding(s) in Company
1st Aug 20137:00 amRNSHalf Yearly Report
17th Jul 20137:00 amRNSNotice of Results
3rd Jul 20137:00 amRNSPre-close Statement
1st Jul 20137:00 amRNSTotal Voting Rights
27th Jun 20134:35 pmRNSPrice Monitoring Extension
25th Jun 20135:26 pmRNSTransfer of Treasury Shares
10th Jun 20134:40 pmRNSSecond Price Monitoring Extn
10th Jun 20134:35 pmRNSPrice Monitoring Extension
3rd Jun 20139:30 amRNSTotal Voting Rights
28th May 20134:44 pmRNSDirector/PDMR Shareholding
24th May 201311:39 amRNSHolding(s) in Company
22nd May 20135:21 pmRNSHolding(s) in Company
20th May 20137:00 amRNSTransaction in Own Shares
16th May 201312:13 pmRNSHolding(s) in Company
14th May 20136:04 pmRNSHolding(s) in Company
14th May 20137:00 amRNSTransaction in Own Shares
10th May 20135:25 pmRNSHolding(s) in Company
1st May 20137:00 amRNSTotal Voting Rights
25th Apr 20137:00 amRNSTransaction in Own Shares
19th Apr 20137:00 amRNSTransaction in Own Shares
18th Apr 20131:08 pmRNSResult of AGM
18th Apr 201311:00 amRNSInterim Management Statement
9th Apr 20137:00 amRNSHolding(s) in Company
9th Apr 20137:00 amRNSTransaction in Own Shares
8th Apr 20137:00 amRNSTransaction in Own Shares
2nd Apr 201311:08 amRNSHolding(s) in Company
2nd Apr 201311:06 amRNSTotal Voting Rights
20th Mar 20134:33 pmRNSDirector's Share Dealing
15th Mar 20137:00 amRNSTransaction in Own Shares
8th Mar 20137:00 amRNSDirectors Shareholding
6th Mar 20137:00 amRNSFinal Results
20th Feb 201310:41 amRNSNotice of Results
8th Feb 20131:01 pmRNSHolding(s) in Company
1st Feb 20137:00 amRNSTotal Voting Rights
28th Jan 20132:05 pmRNSAppointment of Joint Broker
18th Jan 20137:00 amRNSTransaction in Own Shares
16th Jan 20137:00 amRNSTransaction in Own Shares
9th Jan 20137:00 amRNSTransaction in Own Shares
8th Jan 201312:20 pmRNSHolding(s) in Company
4th Jan 20137:04 amRNSPre-close Statement
2nd Jan 20138:36 amRNSTotal Voting Rights
21st Dec 20127:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.